Log in
Enquire now
‌

US Patent 11174252 Heterocyclic compounds as kinase inhibitors

Patent 11174252 was granted and assigned to Nuvation Bio on November, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Nuvation Bio
Nuvation Bio
0
Current Assignee
Nuvation Bio
Nuvation Bio
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
111742520
Patent Inventor Names
Son Minh Pham0
Jiyun Chen0
Sanjeev Soni0
Sarvajit Chakravarty0
Amit Shete0
Anil Kumar Agarwal0
Bhawana Bhatt0
Brahmam Pujala0
...
Date of Patent
November 16, 2021
0
Patent Application Number
162773550
Date Filed
February 15, 2019
0
Patent Primary Examiner
‌
Susanna Moore
0
Patent abstract

Heterocyclic compounds of Formula (J) as CDK4 or CDK6 or other CDK inhibitors are provided. The compounds may find use as therapeutic agents for the treatment of diseases and may find particular use in oncology.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11174252 Heterocyclic compounds as kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.